 | • レポートコード：D0804-08953 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、神経調節装置及び埋め込み型注入ポンプの世界市場を広く調査・分析し、今後の市場展望をまとめております。神経調節装置及び埋め込み型注入ポンプの種類別市場規模（脊髄刺激、深部脳刺激、仙骨神経刺激、迷走神経刺激、胃刺激、経頭蓋磁気刺激、経皮的電気刺激、その他）、用途別市場規模（パーキンソン病、てんかん、痛み、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、Autonomic Technologies、Synapse Biomedical、Boston Scientific Corporation、Cyberonics、Abbott、Greatbatch Medical、Neuropace、Nevro Corporation、Avery Biomedical ・地域別グローバル市場分析 2015年-2020年 ・神経調節装置及び埋め込み型注入ポンプの北米市場（アメリカ、カナダ、メキシコ） ・神経調節装置及び埋め込み型注入ポンプのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経調節装置及び埋め込み型注入ポンプのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経調節装置及び埋め込み型注入ポンプの南米市場（ブラジル、アルゼンチン） ・神経調節装置及び埋め込み型注入ポンプの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：脊髄刺激、深部脳刺激、仙骨神経刺激、迷走神経刺激、胃刺激、経頭蓋磁気刺激、経皮的電気刺激、その他 ・用途別分析：パーキンソン病、てんかん、痛み、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Neuromodulation Devices And Implantable Infusion Pumps market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neuromodulation Devices And Implantable Infusion Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuromodulation Devices And Implantable Infusion Pumps market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuromodulation Devices And Implantable Infusion Pumps market has been segmented into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
By Application, Neuromodulation Devices And Implantable Infusion Pumps has been segmented into:
Parkinson’s disease
Epilepsy
Pain
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuromodulation Devices And Implantable Infusion Pumps market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuromodulation Devices And Implantable Infusion Pumps markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuromodulation Devices And Implantable Infusion Pumps market.
The report offers in-depth assessment of the growth and other aspects of the Neuromodulation Devices And Implantable Infusion Pumps market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuromodulation Devices And Implantable Infusion Pumps Market Share Analysis
Neuromodulation Devices And Implantable Infusion Pumps competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuromodulation Devices And Implantable Infusion Pumps sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuromodulation Devices And Implantable Infusion Pumps sales, revenue and market share for each player covered in this report.
The major players covered in Neuromodulation Devices And Implantable Infusion Pumps are:
Medtronic
Autonomic Technologies
Synapse Biomedical
Boston Scientific Corporation
Cyberonics
Abbott
Greatbatch Medical
Neuropace
Nevro Corporation
Avery Biomedical
Among other players domestic and global, Neuromodulation Devices And Implantable Infusion Pumps market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices And Implantable Infusion Pumps product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices And Implantable Infusion Pumps, with price, sales, revenue and global market share of Neuromodulation Devices And Implantable Infusion Pumps in 2018 and 2019.
Chapter 3, the Neuromodulation Devices And Implantable Infusion Pumps competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices And Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuromodulation Devices And Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuromodulation Devices And Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neuromodulation Devices And Implantable Infusion Pumps Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Parkinson’s disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Overview of Global Neuromodulation Devices And Implantable Infusion Pumps Market
1.4.1 Global Neuromodulation Devices And Implantable Infusion Pumps Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Autonomic Technologies
2.2.1 Autonomic Technologies Details
2.2.2 Autonomic Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Autonomic Technologies SWOT Analysis
2.2.4 Autonomic Technologies Product and Services
2.2.5 Autonomic Technologies Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Synapse Biomedical
2.3.1 Synapse Biomedical Details
2.3.2 Synapse Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Synapse Biomedical SWOT Analysis
2.3.4 Synapse Biomedical Product and Services
2.3.5 Synapse Biomedical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boston Scientific Corporation SWOT Analysis
2.4.4 Boston Scientific Corporation Product and Services
2.4.5 Boston Scientific Corporation Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cyberonics
2.5.1 Cyberonics Details
2.5.2 Cyberonics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cyberonics SWOT Analysis
2.5.4 Cyberonics Product and Services
2.5.5 Cyberonics Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Greatbatch Medical
2.7.1 Greatbatch Medical Details
2.7.2 Greatbatch Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Greatbatch Medical SWOT Analysis
2.7.4 Greatbatch Medical Product and Services
2.7.5 Greatbatch Medical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Neuropace
2.8.1 Neuropace Details
2.8.2 Neuropace Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Neuropace SWOT Analysis
2.8.4 Neuropace Product and Services
2.8.5 Neuropace Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nevro Corporation
2.9.1 Nevro Corporation Details
2.9.2 Nevro Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nevro Corporation SWOT Analysis
2.9.4 Nevro Corporation Product and Services
2.9.5 Nevro Corporation Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Avery Biomedical
2.10.1 Avery Biomedical Details
2.10.2 Avery Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Avery Biomedical SWOT Analysis
2.10.4 Avery Biomedical Product and Services
2.10.5 Avery Biomedical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuromodulation Devices And Implantable Infusion Pumps Manufacturer Market Share in 2019
3.3.2 Top 6 Neuromodulation Devices And Implantable Infusion Pumps Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Regions
4.1.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
4.3 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
4.5 South America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Country
5.1.1 North America Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Country (2015-2020)
5.2 United States Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
5.3 Canada Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
5.4 Mexico Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Country
6.1.1 Europe Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.3 UK Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.4 France Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.5 Russia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
6.6 Italy Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Regions (2015-2020)
7.2 China Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.3 Japan Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.4 Korea Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.5 India Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
7.7 Australia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Country
8.1.1 South America Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
8.3 Argentina Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.3 Turkey Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.4 Egypt Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
9.5 South Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales and Market Share by Type (2015-2020)
10.2 Global Neuromodulation Devices And Implantable Infusion Pumps Revenue and Market Share by Type (2015-2020)
10.3 Global Neuromodulation Devices And Implantable Infusion Pumps Price by Type (2015-2020)
11 Global Neuromodulation Devices And Implantable Infusion Pumps Market Segment by Application
11.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
11.2 Global Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Application (2015-2020)
11.3 Global Neuromodulation Devices And Implantable Infusion Pumps Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuromodulation Devices And Implantable Infusion Pumps Market Forecast by Regions (2021-2025)
12.2.1 North America Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025)
12.2.2 Europe Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025)
12.2.4 South America Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025)
12.3 Neuromodulation Devices And Implantable Infusion Pumps Market Forecast by Type (2021-2025)
12.3.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales Forecast by Type (2021-2025)
12.3.2 Global Neuromodulation Devices And Implantable Infusion Pumps Market Share Forecast by Type (2021-2025)
12.4 Neuromodulation Devices And Implantable Infusion Pumps Market Forecast by Application (2021-2025)
12.4.1 Global Neuromodulation Devices And Implantable Infusion Pumps Sales Forecast by Application (2021-2025)
12.4.2 Global Neuromodulation Devices And Implantable Infusion Pumps Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuromodulation Devices And Implantable Infusion Pumps by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Medtronic Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 9. Medtronic Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 10. Medtronic SWOT Analysis
Table 11. Medtronic Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 12. Medtronic Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Autonomic Technologies Basic Information, Manufacturing Base and Competitors
Table 14. Autonomic Technologies Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 15. Autonomic Technologies Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 16. Autonomic Technologies SWOT Analysis
Table 17. Autonomic Technologies Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 18. Autonomic Technologies Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 20. Synapse Biomedical Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 21. Synapse Biomedical Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 22. Synapse Biomedical SWOT Analysis
Table 23. Synapse Biomedical Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 24. Synapse Biomedical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 26. Boston Scientific Corporation Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 27. Boston Scientific Corporation Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 28. Boston Scientific Corporation SWOT Analysis
Table 29. Boston Scientific Corporation Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 30. Boston Scientific Corporation Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Cyberonics Basic Information, Manufacturing Base and Competitors
Table 32. Cyberonics Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 33. Cyberonics Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 34. Cyberonics SWOT Analysis
Table 35. Cyberonics Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 36. Cyberonics Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Abbott Basic Information, Manufacturing Base and Competitors
Table 38. Abbott Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 39. Abbott Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 40. Abbott SWOT Analysis
Table 41. Abbott Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 42. Abbott Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Greatbatch Medical Basic Information, Manufacturing Base and Competitors
Table 44. Greatbatch Medical Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 45. Greatbatch Medical Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 46. Greatbatch Medical SWOT Analysis
Table 47. Greatbatch Medical Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 48. Greatbatch Medical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Neuropace Basic Information, Manufacturing Base and Competitors
Table 50. Neuropace Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 51. Neuropace Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 52. Neuropace SWOT Analysis
Table 53. Neuropace Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 54. Neuropace Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Nevro Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Nevro Corporation Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 57. Nevro Corporation Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 58. Nevro Corporation SWOT Analysis
Table 59. Nevro Corporation Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 60. Nevro Corporation Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Avery Biomedical Basic Information, Manufacturing Base and Competitors
Table 62. Avery Biomedical Neuromodulation Devices And Implantable Infusion Pumps Major Business
Table 63. Avery Biomedical Neuromodulation Devices And Implantable Infusion Pumps Total Revenue (USD Million) (2018-2019)
Table 64. Avery Biomedical SWOT Analysis
Table 65. Avery Biomedical Neuromodulation Devices And Implantable Infusion Pumps Product and Services
Table 66. Avery Biomedical Neuromodulation Devices And Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Neuromodulation Devices And Implantable Infusion Pumps Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Neuromodulation Devices And Implantable Infusion Pumps Sales by Regions (2015-2020) (K Units)
Table 70. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Regions (2015-2020)
Table 71. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020) (K Units)
Table 73. North America Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries (2015-2020)
Table 74. North America Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020)
Table 76. Europe Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020) (K Units)
Table 77. Europe Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries (2015-2020)
Table 78. Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020) (K Units)
Table 83. South America Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries (2015-2020)
Table 84. South America Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020)
Table 90. Global Neuromodulation Devices And Implantable Infusion Pumps Sales by Type (2015-2020) (K Units)
Table 91. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Share by Type (2015-2020)
Table 92. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue by Type (2015-2020) (USD Million)
Table 93. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue Share by Type (2015-2020)
Table 94. Global Neuromodulation Devices And Implantable Infusion Pumps Sales by Application (2015-2020) (K Units)
Table 95. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Share by Application (2015-2020)
Table 96. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Neuromodulation Devices And Implantable Infusion Pumps Market Share Forecast by Regions (2021-2025)
Table 98. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Neuromodulation Devices And Implantable Infusion Pumps Market Share Forecast by Type (2021-2025)
Table 100. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Forecast by Application (2021-2025)
Table 101. Global Neuromodulation Devices And Implantable Infusion Pumps Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuromodulation Devices And Implantable Infusion Pumps Picture
Figure 2. Global Sales Market Share of Neuromodulation Devices And Implantable Infusion Pumps by Type in 2019
Figure 3. Spinal Cord Stimulation Picture
Figure 4. Deep Brain Stimulation Picture
Figure 5. Sacral Nerve Stimulation Picture
Figure 6. Vagal Nerve Stimulation Picture
Figure 7. Gastric Stimulation Picture
Figure 8. Transcranial magnetic Stimulation Picture
Figure 9. Transcutaneous Electrical Stimulation Picture
Figure 10. Other Picture
Figure 11. Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Application in 2018
Figure 12. Parkinson's disease Picture
Figure 13. Epilepsy Picture
Figure 14. Pain Picture
Figure 15. Other Picture
Figure 16. Global Neuromodulation Devices And Implantable Infusion Pumps Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Neuromodulation Devices And Implantable Infusion Pumps Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Manufacturer in 2019
Figure 37. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Neuromodulation Devices And Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Neuromodulation Devices And Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 42. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Regions (2015-2020)
Figure 44. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Regions in 2018
Figure 45. North America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
Figure 46. Europe Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
Figure 48. South America Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020)
Figure 50. North America Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries (2015-2020)
Figure 52. North America Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries in 2018
Figure 53. North America Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries in 2018
Figure 55. United States Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Canada Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Mexico Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries in 2019
Figure 61. Germany Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 62. UK Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 63. France Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Russia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Italy Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Regions 2019
Figure 69. China Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Japan Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Korea Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 72. India Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Southeast Asia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 74. South America Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries in 2019
Figure 76. South America Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries in 2019
Figure 77. Brazil Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Argentina Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Neuromodulation Devices And Implantable Infusion Pumps Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Egypt Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Turkey Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 86. South Africa Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Global Neuromodulation Devices And Implantable Infusion Pumps Sales and Growth Rate (2021-2025) (K Units)
Figure 88. Global Neuromodulation Devices And Implantable Infusion Pumps Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025) (K Units)
Figure 90. Europe Sales Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025) (K Units)
Figure 91. Asia-Pacific Sales Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025) (K Units)
Figure 92. South America Sales Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025) (K Units)
Figure 93. Middle East & Africa Sales Neuromodulation Devices And Implantable Infusion Pumps Market Forecast (2021-2025) (K Units)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
経皮的電気神経筋刺激の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Transcutaneous Electrical Nerve Muscle Stimulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…- パーキンソン病脳深部刺激・サービスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Deep Brain Stimulation and Service for Parkinson’s Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mark…
- 神経筋刺激装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neuromuscular Stimulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuromuscular Stimu…
- デジタル片頭痛治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Digital Migraine Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- テーブルトップ電気筋肉刺激装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Table Top Electrical Muscle Stimulator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…